Induction of Cyclooxygenase (COX)-2 in Human Vaginal Epithelial Cells in Response to TLR ligands and TNF-α

American Journal of Reproductive Immunology

Volumn 67, Issue 6, 2012, Pages 482-490

  Joseph, Theresa ^a   Zalenskaya, Irina A ^a   Yousefieh, Nazita ^a   Schriver, Suzanne D ^a   Cote, Lyn C ^a   Chandra, Neelima ^a   Doncel, Gustavo F ^a  

^a EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

Author keywords

COX 2; Genital; HIV; Inflammation; Prostaglandin; TLRs

Indexed keywords

CYCLOOXYGENASE 2; IMIQUIMOD; LIGAND; LIPOTEICHOIC ACID; MACROPHAGE ACTIVATING LIPOPEPTIDE 2; MESSENGER RNA; PROSTAGLANDIN E2; PROTEIN PAM3CSK4; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ZYMOSAN;

ARTICLE; CELL CULTURE; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MICROARRAY ANALYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SUPERNATANT; TRANSCRIPTION INITIATION; UTERINE CERVIX BIOPSY; VAGINA EPITHELIUM; VAGINITIS;

AMINOQUINOLINES; CELL LINE; CYCLOOXYGENASE 2; DINOPROSTONE; EPITHELIAL CELLS; FEMALE; HUMANS; LIGANDS; LIPOPEPTIDES; LIPOPOLYSACCHARIDES; POLYDEOXYRIBONUCLEOTIDES; RNA, MESSENGER; TEICHOIC ACIDS; TOLL-LIKE RECEPTORS; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION; VAGINA; ZYMOSAN;

EID: 84860920302     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/j.1600-0897.2011.01099.x     Document Type: Article

References (40)

1. Galvin SR, Cohen MS: The role of sexually transmitted diseases in HIV transmission. Nat Rev Microbiol 2004; 2:33-42.
2. Fichorova RN, Cronin AO, Lien E, Anderson DJ, Ingalls RR: Response to Neisseria gonorrhoeae by cervicovaginal epithelial cells occurs in the absence of toll-like receptor 4-mediated signaling. J Immunol 2002; 168:2424-2432.
3. Wira CR, Patel MV, Ghosh M, Mukura L, Fahey JV: Innate immunity in the human female reproductive tract: endocrine regulation of endogenous antimicrobial protection against HIV and other sexually transmitted infections. Am J Reprod Immunol 2011; 65:196-211.
4. Medzhitov R, Janeway C Jr: The Toll receptor family and microbial recognition. Trends Microbiol 2000; 8:452-456.
5. Gribar SC, Richardson WM, Sodhi CP, Hackam DJ: No longer an innocent bystander: epithelial toll-like receptor signaling in the development of mucosal inflammation. Mol Med 2008; 14:645-659.
6. Herbst-Kralovetz MM, Quayle AJ, Ficarra M, Greene S, Rose WA II, Chesson R, Spagnuolo RA, Pyles RB: Quantification and comparison of toll-like receptor expression and responsiveness in primary and immortalized human female lower genital tract epithelia. Am J Reprod Immunol 2008; 59:212-224.
7. Herbst-Kralovetz M, Pyles R: Toll-like receptors, innate immunity and HSV pathogenesis. Herpes 2006; 13:37-41.
8. Wang Y, Abel K, Lantz K, Krieg AM, McChesney MB, Miller CJ: The Toll-like receptor 7 (TLR7) agonist, imiquimod, and the TLR9 agonist, CpG ODN, induce antiviral cytokines and chemokines but do not prevent vaginal transmission of simian immunodeficiency virus when applied intravaginally to rhesus macaques. J Virol 2005; 79:14355-14370.
9. Turini ME, DuBois RN: Cyclooxygenase-2: a therapeutic target. Annu Rev Med 2002; 53:35-57.
10. Chen CC: Signal transduction pathways of inflammatory gene expressions and therapeutic implications. Curr Pharm Des 2006; 12:3497-3508.
11. N'Guessan PD, Hippenstiel S, Etouem MO, Zahlten J, Beermann W, Lindner D, Opitz B, Witzenrath M, Rosseau S, Suttorp N, Schmeck B: Streptococcus pneumoniae induced p38 MAPK- and NF-kappaB-dependent COX-2 expression in human lung epithelium. Am J Physiol Lung Cell Mol Physiol 2006; 290:L1131-1138.
12. Fukata M, Chen A, Klepper A, Krishnareddy S, Vamadevan AS, Thomas LS, Xu R, Inoue H, Arditi M, Dannenberg AJ, Abreu MT: Cox-2 is regulated by Toll-like receptor-4 (TLR4) signaling: role in proliferation and apoptosis in the intestine. Gastroenterology 2006; 131:862-877.
13. Mitsunari M, Yoshida S, Shoji T, Tsukihara S, Iwabe T, Harada T, Terakawa N: Macrophage-activating lipopeptide-2 induces cyclooxygenase-2 and prostaglandin E(2) via toll-like receptor 2 in human placental trophoblast cells. J Reprod Immunol 2006; 72:46-59.
14. Deva R, Shankaranarayanan P, Ciccoli R, Nigam S: Candida albicans induces selectively transcriptional activation of cyclooxygenase-2 in HeLa cells: pivotal roles of Toll-like receptors, p38 mitogen-activated protein kinase, and NF-kappa B. J Immunol 2003; 171:3047-3055.
15. Kucknoor A, Mundodi V, Alderete JF: Trichomonas vaginalis adherence mediates differential gene expression in human vaginal epithelial cells. Cell Microbiol 2005; 7:887-897.
16. Zalenskaya IA, Cerocchi OG, Joseph T, Donaghay MA, Schriver SD, Doncel GF: Increased COX-2 expression in human vaginal epithelial cells exposed to nonoxynol-9, a vaginal contraceptive microbicide that failed to protect women from HIV-1 infection. Am J Reprod Immunol 2011; 65:569-577.
17. Doncel GF, Chandra N, Fichorova RN: Preclinical assessment of the proinflammatory potential of microbicide candidates. J Acquir Immune Defic Syndr 2004; 37(Suppl 3):S174-180.
18. Fichorova RN, Rheinwald JG, Anderson DJ: Generation of papillomavirus-immortalized cell lines from normal human ectocervical, endocervical, and vaginal epithelium that maintain expression of tissue-specific differentiation proteins. Biol Reprod 1997; 57:847-855.
19. Irizarry RA, Ooi SL, Wu Z, Boeke JD: Use of mixture models in a microarray-based screening procedure for detecting differentially represented yeast mutants. Stat Appl Genet Mol Biol 2003; 2:Article 1.
20. Benjamini Y, Hochberg Y: Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Series B Stat Methodol 1995; 57:289-300.
21. Masferrer JL, Zweifel BS, Manning PT, Hauser SD, Leahy KM, Smith WG, Isakson PC, Seibert K: Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic. Proc Natl Acad Sci U S A 1994; 91:3228-3232.
22. Quayle AJ: The innate and early immune response to pathogen challenge in the female genital tract and the pivotal role of epithelial cells. J Reprod Immunol 2002; 57:61-79.
23. Nasu K, Narahara H: Pattern recognition via the toll-like receptor system in the human female genital tract. Mediators Inflamm 2010; 2010:976024.
24. Williams TJ, Morley J: Prostaglandins as potentiators of increased vascular permeability in inflammation. Nature 1973; 246:215-217.
25. Aliprantis AO, Yang RB, Mark MR, Suggett S, Devaux B, Radolf JD, Klimpel GR, Godowski P, Zychlinsky A: Cell activation and apoptosis by bacterial lipoproteins through toll-like receptor-2. Science 1999; 285:736-739.
26. Underhill DM, Ozinsky A, Smith KD, Aderem A: Toll-like receptor-2 mediates mycobacteria-induced proinflammatory signaling in macrophages. Proc Natl Acad Sci U S A 1999; 96:14459-14463.
27. Takeuchi O, Hoshino K, Akira S: Cutting edge: TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection. J Immunol 2000; 165:5392-5396.
28. Takeuchi O, Sato S, Horiuchi T, Hoshino K, Takeda K, Dong Z, Modlin RL, Akira S: Cutting edge: role of Toll-like receptor 1 in mediating immune response to microbial lipoproteins. J Immunol 2002; 169:10-14.
29. Alexopoulou L, Holt AC, Medzhitov R, Flavell RA: Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 2001; 413:732-738.
30. Hemmi H, Kaisho T, Takeuchi O, Sato S, Sanjo H, Hoshino K, Horiuchi T, Tomizawa H, Takeda K, Akira S: Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway. Nat Immunol 2002; 3:196-200.
31. Moore RA, Edwards JE, Hopwood J, Hicks D: Imiquimod for the treatment of genital warts: a quantitative systematic review. BMC Infect Dis 2001; 1:3.
32. Otte JM, Cario E, Podolsky DK: Mechanisms of cross hyporesponsiveness to Toll-like receptor bacterial ligands in intestinal epithelial cells. Gastroenterology 2004; 126:1054-1070.
33. Akinbiyi AA, Watson R, Feyi-Waboso P: Prevalence of Candida albicans and bacterial vaginosis in asymptomatic pregnant women in South Yorkshire, United Kingdom. Outcome of a prospective study. Arch Gynecol Obstet 2008; 278:463-466.
34. Podlech J, Hengerer F, Fleck M, Eray K, Falke D: Asymptomatic vaginal herpes simplex virus infections in mice: virology and pathohistology. Arch Virol 1996; 141:263-274.
35. Tilley SL, Coffman TM, Koller BH: Mixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes. J Clin Invest 2001; 108:15-23.
36. Steer SA, Corbett JA: The role and regulation of COX-2 during viral infection. Viral Immunol 2003; 16:447-460.
37. Dumais N, Bounou S, Olivier M, Tremblay MJ: Prostaglandin E(2)-mediated activation of HIV-1 long terminal repeat transcription in human T cells necessitates CCAAT/enhancer binding protein (C/EBP) binding sites in addition to cooperative interactions between C/EBPbeta and cyclic adenosine 5′-monophosphate response element binding protein. J Immunol 2002; 168:274-282.
38. Lima RG, Moreira L, Paes-Leme J, Barreto-de-Souza V, Castro-Faria-Neto HC, Bozza PT, Bou-Habib DC: Interaction of macrophages with apoptotic cells enhances HIV Type 1 replication through PGE2, PAF, and vitronectin receptor. AIDS Res Hum Retroviruses 2006; 22:763-769.
39. Schroer J, Shenk T: Inhibition of cyclooxygenase activity blocks cell-to-cell spread of human cytomegalovirus. Proc Natl Acad Sci U S A 2008; 105:19468-19473.
40. Kvale D, Ormaasen V, Kran AM, Johansson CC, Aukrust P, Aandahl EM, Froland SS, Tasken K: Immune modulatory effects of cyclooxygenase type 2 inhibitors in HIV patients on combination antiretroviral treatment. AIDS 2006; 20:813-820.